Aino Health (AINO.ST) Stock Analysis & AI Equity Report
Aino Health (AINO.ST) overview
Aino Health (AINO.ST) stock analysis and AI equity research. For the latest completed financial year, 2025, Aino Health reported revenue of SEK 26.1m and operating profit of SEK -5.2m; the year-end share price was 0.17 SEK and market capitalisation was SEK 35.0m. Aino Health is covered by Valuatum but does not yet have a published AI equity report. Generate a fresh report to get Aino Health's valuation, segment value analysis, reverse valuation, financial forecasts, key ratios, risks and catalysts.
Key metrics & valuation multiples
Figures updated on 2026-05-14. Data will be refreshed during report generation.
About Aino Health
Aino Health AB provides SaaS solutions and related services for corporate health management. Its platform helps employers manage work ability, track sickness absence, identify underlying causes of employee health issues, and support proactive interventions. The company serves public and private organizations, with revenue driven by software subscriptions, implementation, and customer support services.
Generate the Aino Health report
Aino Health is on Valuatum's coverage list, but a full AI equity report hasn't been generated yet. Order one now for the complete company value map, reverse valuation, risk & catalyst analysis, and financial statements and estimates — plus a downloadable PDF.
Sources & methodology
Financial figures are sourced from Valuatum's financial model for Aino Health and represent the latest completed financial year (2025). See the methodology for the full Valuatum AI equity research framework.
Disclaimer: This is an AI-generated research material for informational purposes only. It is not investment advice or a buy/sell recommendation. Always perform your own analysis. Valuatum Oy, Helsinki, Finland.